Healthcare
Karyopharm Therapeutics Inc.
KPTI$2.06+10.16%
Price is delayed.
Add to Watchlist
About Karyopharm Therapeutics Inc.
Karyopharm Therapeutics is a drug company that develops cancer medicines. The company's main product is called XPOVIO, which is used to treat multiple myeloma (a blood cancer) and a type of lymphoma. XPOVIO works by blocking a protein that helps cancer cells survive, and doctors give it alongside other established cancer drugs. Karyopharm is also testing other similar drugs for different cancers, including endometrial cancer and myelofibrosis.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore